Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H22N2 |
| Molecular Weight | 266.3807 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1CCC(CC1)NC2=CC=C(NC3=CC=CC=C3)C=C2
InChI
InChIKey=ZRMMVODKVLXCBB-UHFFFAOYSA-N
InChI=1S/C18H22N2/c1-3-7-15(8-4-1)19-17-11-13-18(14-12-17)20-16-9-5-2-6-10-16/h1,3-4,7-8,11-14,16,19-20H,2,5-6,9-10H2
| Molecular Formula | C18H22N2 |
| Molecular Weight | 266.3807 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine is a component of black rubber. It is also a dermatological sensitizer and allergen. N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:04:04 GMT 2023
by
admin
on
Fri Dec 15 17:04:04 GMT 2023
|
| Record UNII |
T29JGK5V4R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
T29JGK5V4R
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | |||
|
DTXSID2051508
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | |||
|
N0000175629
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | Increased Histamine Release [PE] | ||
|
100000134270
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | |||
|
92093
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | |||
|
N0000171131
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
DB14196
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | |||
|
101-87-1
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | |||
|
1427136
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | RxNorm | ||
|
N0000184306
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
T29JGK5V4R
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY | |||
|
202-984-9
Created by
admin on Fri Dec 15 17:04:04 GMT 2023 , Edited by admin on Fri Dec 15 17:04:04 GMT 2023
|
PRIMARY |